↓ Skip to main content

Cochrane Database of Systematic Reviews

GLP‐1 receptor agonists for Parkinson's disease

Overview of attention for article published in Cochrane database of systematic reviews, July 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
32 news outlets
blogs
1 blog
twitter
15 X users

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
188 Mendeley
Title
GLP‐1 receptor agonists for Parkinson's disease
Published in
Cochrane database of systematic reviews, July 2020
DOI 10.1002/14651858.cd012990.pub2
Pubmed ID
Authors

Caroline A Mulvaney, Gonçalo S Duarte, Joel Handley, David Jw Evans, Suresh Menon, Richard Wyse, Hedley Ca Emsley

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 188 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 12%
Student > Bachelor 16 9%
Researcher 13 7%
Other 10 5%
Student > Ph. D. Student 8 4%
Other 25 13%
Unknown 93 49%
Readers by discipline Count As %
Medicine and Dentistry 40 21%
Nursing and Health Professions 12 6%
Biochemistry, Genetics and Molecular Biology 7 4%
Neuroscience 6 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 21 11%
Unknown 97 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 257. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 May 2024.
All research outputs
#148,926
of 26,179,045 outputs
Outputs from Cochrane database of systematic reviews
#263
of 13,190 outputs
Outputs of similar age
#4,785
of 432,430 outputs
Outputs of similar age from Cochrane database of systematic reviews
#8
of 185 outputs
Altmetric has tracked 26,179,045 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,190 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,430 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.